Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00322452
Status:
COMPLETED
Last Update Posted:
2013-11-07
First Post:
2006-05-05
Brief Title:
First Line IRESSA Versus CarboplatinPaclitaxel in Asia
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-03
Start Date Type:
None
Primary Completion Date:
2008-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-06
Completion Date Type:
ACTUAL
First Submit Date:
2006-05-05
First Submit QC Date:
May 5 2006
Study First Post Date:
2006-05-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2010-05-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-10-14
Last Update Post Date:
2013-11-07
Last Update Post Date Type:
ESTIMATED